Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 1850785Generated: November 1, 2026

Azetidine → HCID 70856360, compound

https://huagongshe.com/reaction/1850785

Reaction equation

Participants

RoleNameHCIDCharge
ReactantAzetidineHCID 10422—
ReactantDiisopropylethylamineHCID 81531—
ReactantMethanaminium, N-((dimethylamino)(3H-1,2,3-triazolo(4,5-b)pyridin-3-yloxy)methylene)-N-methyl-, hexafluorophosphate(1-) (1:1)HCID 9886157—
ReactantHCID 86711203HCID 86711203—
SolventDimethylformamideHCID 6228—
ProductHCID 70856360HCID 70856360—

Reaction Steps

To a solution of (2,6-difluoro-4-{2-[(1S,2R)-2-{1-[3-(methoxymethyl)-1,2,4-oxadiazol-5-yl]piperidin-4-yl}cyclopropyl]ethoxy}phenyl)acetic acid (100 mg, 0.230 mmol) (from example 1, step C) in 1 ml anhydrous DMF at RT was added azetidine (13.2 mg, 0.230 mmol) and N,N-diisopropylethylamine (0.201 ml, 1.15 mmol). o-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate (175 mg, 0.461 mmol) was added into the solution and stirred at RT for 4 hrs. The reaction mixture was filtered and purified by reverse-phase HPLC (SunFire Prep C18 OBD 5 um 19×100 mm column; 35-100% acetonitrile in 0.1% formic acid in water gradient) to give the title compound. LC/MS (m/z): 509.4.2 (M+H)+. GPR119 Human EC50:1.4 nM.

Provenance & Evidence

DOI10.6084/m9.figshare.5104873.v1
Patent numberUS08957062B2
Source datasetuspto-grants-2015_02
ORD IDord-922ec6333b2e4800aa8ea96a6f4e0c69
Source noteuspto-grants-2015_02